CREB3L4 promotes hepatocellular carcinoma progression and decreases sorafenib chemosensitivity by promoting RHEB-mTORC1 signaling pathwayZhengchen Jiang(Shandong Provincial QianFoShan Hospital), Xiaomin Ma(Shandong University)iScienceJanuary 9, 202410.1016/j.isci.2024.108843Cited by 9SaveCiteExport RISWatch citationsRelated PapersLoss of AIM2 expression promotes hepatocarcinoma progression through activation of mTOR-S6K1 pathway|Oncotarget|2016|130NOD2 inhibits tumorigenesis and increases chemosensitivity of hepatocellular carcinoma by targeting AMPK pathway|Cell Death and Disease|2020|83The E3 ubiquitin ligase MG53 inhibits hepatocellular carcinoma by targeting RAC1 signaling|Oncogenesis|2022|28